First Time Loading...

Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 5.27 USD -3.83% Market Closed
Updated: May 21, 2024

Vanda Pharmaceuticals Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vanda Pharmaceuticals Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Total Other Income
$21.3m
CAGR 3-Years
89%
CAGR 5-Years
37%
CAGR 10-Years
64%
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.5B
CAGR 3-Years
12%
CAGR 5-Years
-62%
CAGR 10-Years
-78%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$158m
CAGR 3-Years
4%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$55.2m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vanda Pharmaceuticals Inc's Total Other Income?
Total Other Income
21.3m USD

Based on the financial report for Mar 31, 2024, Vanda Pharmaceuticals Inc's Total Other Income amounts to 21.3m USD.

What is Vanda Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
64%

Over the last year, the Total Other Income growth was 155%. The average annual Total Other Income growth rates for Vanda Pharmaceuticals Inc have been 89% over the past three years , 37% over the past five years , and 64% over the past ten years .